for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Gimv Investeringsmaatschap Vor Vlndrn NV

GIMV.BR

Latest Trade

55.10EUR

Change

0.00(0.00%)

Volume

2,540

Today's Range

54.50

 - 

55.10

52 Week Range

45.50

 - 

56.50

As of on the Euronext Brussels ∙ Minimum 15 minute delay

Pricing

Previous Close
55.10
Open
54.70
Volume
2,540
3M AVG Volume
0.26
Today's High
55.10
Today's Low
54.50
52 Week High
56.50
52 Week Low
45.50
Shares Out (MIL)
25.43
Market Cap (MIL)
1,380.67
Forward P/E
--
Dividend (Yield %)
3.22

Latest Developments

More

Istar Medical Announces EUR 40.1 mln Financing Round Lead By GIMV

GIMV Announces Its Exit From French Company Groupe Legallais

GIMV And Other Shareholders Sell Company Breath Therapeutics To Zambon

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Gimv Investeringsmaatschap Vor Vlndrn NV

Gimv Investeringsmaatschappij Voor Vlanderen NV, formerly Gimv NV, is a Belgium-based investment provider of private equity and venture capital. In the Buyouts & Growth segment, the Company has four business units in Belgium, the Netherlands, Germany and France. The Technology, Life Sciences and Cleantech trends business units together form the Venture Capital segment. The Funds & Joint Ventures segment is formed by Gimv-XL, Gimv-Agri+, Central Europe & Russia, DG Infra+ and other funds. Through EcoChem International, it invests in innovation, product development, manufacturing and distribution of eco-friendly flame retardant additives. Through the DG Infra+ fund the Company invests companies, projects and infrastructure related assets in sectors, such as transport and logistics infrastructure, utilities, social and healthcare infrastructure, and communication networks. It operates through Summa, France Thermes, Acceo, AgroBiothers, IMPACT, Rovipharm and Nova Engineering.

Industry

Misc. Financial Services

Contact Info

Karel Oomsstraat 37

+32.3.2902100

http://www.gimv.com

Executive Leadership

Hilde Laga

Chairman of the Board

Koen Dejonckheere

Chief Executive Officer, Executive Director

Kristof Vande Capelle

Chief Financial Officer

Edmond Bastijns

Chief Legal Officer and Secretary General

Dirk Dewals

Head Connected Consumer

Key Stats

2.67 mean rating - 3 analysts
Sell
Hold
Buy
Price To Earnings (TTM)
12.32
Price To Sales (TTM)
6.15
Price To Book (MRQ)
1.04
Price To Cash Flow (TTM)
11.69
Total Debt To Equity (MRQ)
0.00
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
8.94
Return on Equity (TTM)
8.57

Latest News

BRIEF-Gimv Obtains Majority Interest In Specialised Staffing Agency Impact

* OBTAINS MAJORITY INTEREST IN SPECIALISED STAFFING AGENCY IMPACT

BRIEF-Gimv Acquires Majority Stake In France Thermes

* GIMV ACQUIRES A MAJORITY STAKE IN THE CAPITAL OF FRANCE THERMES IN ORDER TO SUPPORT THE GROUP\'S AMBITIOUS GROWTH PLANS

BRIEF-Gimv Invests ‍Eur 7 Million In Fire1 ​

* GIMV INVESTS IN FIRE1, A MEDTECH COMPANY DEVELOPING A CONNECTED NOVEL HEART MONITORING SOLUTION

BRIEF-Gimv And ‍Merieux Developpement Sign Exclusivity Agreement To Acquire Stiplastics Healthcaring​

* MÉRIEUX DÉVELOPPEMENT AND GIMV SIGN EXCLUSIVITY AGREEMENT WITH VIEW TO ACQUIRING STIPLASTICS HEALTHCARING

BRIEF-Gimv Agrees To Sell Its Shares In Mackevision To Accenture

* GIMV AGREES TO SELL ITS SHARES IN MACKEVISION TO ACCENTURE Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Gimv Divests Brakel To Kingspan

* DIVESTS NATURAL CLIMATE CONTROL AND FIRE SAFETY SPECIALIST BRAKEL TO KINGSPAN Source text: http://bit.ly/2i8PJor Further company coverage: (Gdynia Newsroom)

BRIEF-Gimv H1 net profit group share down at 62.6 million euros

* H1 NET PROFIT GROUP SHARE EUR 62.6 MILLION VERSUS EUR 97.8 MILLION YEAR AGO

BRIEF-Gimv to acquire equity stake in Agrobiothers​

* GIMV AND JENOUDET FAMILY TODAY ANNOUNCED THAT THEY HAVE SIGNED AN AGREEMENT REGARDING THIS ACUISITION

BRIEF-Gimv-backed Luciad acquired by Hexagon

GIMV INVESTERINGSMAATSCHAPPIJ VOOR VLANDEREN NV:

BRIEF-Gimv acquires a majority stake in Wemas

* TRANSACTION IS SUBJECT TO APPROVAL BY COMPETITION AUTHORITIES. NO FURTHER FINANCIAL DETAILS OF TRANSACTION WILL BE ANNOUNCED Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Gimv acquires 23.6 percent of Cegeka shares

* GIMV ACQUIRES 23.6 PERCENT OF CEGEKA SHARES Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Gimv reports net cash position at June 30, at 303.3 million euros

* NET CASH POSITION AT JUNE 30: EUR 303.3 MILLION AFTER DIVIDEND PAYMENTS ON 5 JULY 2017

BRIEF-GIMV invests in Snack Connection

* INVESTMENT WILL LEAD TO CO'S ACQUISITION OF CURRENT MAJOR SHAREHOLDER TROPHAS' SHARE

BRIEF-Gimv takes substantial interest in Arseus Medical

* ANNOUNCED AN INVESTMENT OF EUR 15 MILLION IN ARSEUS MEDICAL

BRIEF-Gimv FY operating income rises to 271.8 million euros

* FY OPERATING INCOME EUR 271.8 MILLION VERSUS EUR 266.9 MILLION YEAR AGO

BRIEF-Gimv enters into a partnership with MVZ Holding

GIMV INVESTERINGSMAATSCHAPPIJ VOOR VLANDEREN NV

BRIEF-Gimv co-leads 43.5 million euros financing of Breath Therapeutics

Gimv Investeringsmaatschappij Voor Vlanderen NV:

BRIEF-GIMV net cash position at end of 9 months at 328.9 mln euros

Gimv Investeringsmaatschappij Voor Vlanderen NV:

BRIEF-Gimv H1 net result (group's share) up at 85.1 million euros

Gimv Investeringsmaatschappij Voor Vlanderen Nv

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up